Skip to content

Synthorx, Inc.

Delisted

CIK 1609727fmd_11F1EPGK85VETYCS99Q6SEQ0MRManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2018 to Sep 30, 2019, 6 periods

Latest quarter · Q3 FY2019

Millions
Operating income
(13)
Net income
(12)
Free cash flow
(15)
Open Financials